Working towards more responsible research assessment
A member of EMBL’s Responsible Research Assessment Working Group shares his thoughts on the importance of reforming strategies to assess research and researchers.
LAB MATTERS2024
lab-matters
Better together: gut microbiome communities’ resilience to drugs
EMBL Heidelberg researchers compared the effect of drugs on isolated bacteria versus those growing in communities. This is the first study showing that bacteria are more resilient when in community due to cross-protection strategies. This could help researchers design more efficient therapies.
SCIENCE & TECHNOLOGY2024
science-technology
Gaining skills and building connections in infection biology
The first EMBL-UNESCO infection biology research fellows share observations after residencies with EMBL researchers.
LAB MATTERSPEOPLE & PERSPECTIVES2024
lab-matterspeople-perspectivesperspectives
Fighting antimicrobial resistance with new drug combinations
In an extensive investigation, EMBL researchers have tested over 10,000 drug combinations against some of the leading pathogenic bacteria carrying antimicrobial resistance and causing mortality.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
Spotlight: Establishing a colour palette for antibiotic resistance
To identify which drugs disrupt bacterial envelope integrity, the Typas group uses a molecule called chlorophenyl red-β-D-galactopyranoside.
LAB MATTERSSCIENCE & TECHNOLOGY2022
lab-matterspicture-of-the-weekscience-technology
The retron switch
EMBL researchers now understand the function of an elusive small DNA in bacteria and have developed a tool that can be used to better understand what might ‘switch on’ bacterial immune defences.
SCIENCE & TECHNOLOGY2022
sciencescience-technology
Three EMBL scientists elected as EMBO Members
Cornelius Gross, Miki Ebisuya and Nassos Typas join EMBO, the prestigious organisation for the life sciences.
EMBL ANNOUNCEMENTSLAB MATTERS2022
embl-announcementslab-matters
Characterising protein phosphosite function at scale
Researchers develop a new high-throughput approach to assess the functional significance of protein phosphosites.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Tackling the collateral damage from antibiotics
Researchers from EMBL’s Typas group and collaborators have analysed the effects of 144 antibiotics on the wellbeing of gut microbes. The study improves our understanding of antibiotics’ side effects and suggests a new approach to mitigating the adverse effects of antibiotics therapy on gut…
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Common medications accumulate in gut bacteria
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
New insights into Salmonella’s survival strategies
Research in the Typas group uncovers new details of the strategies Salmonella uses to survive in infected cells.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Finding coronavirus’s helper proteins
A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Heating proteins to understand how genes work
A new paper from EMBL’s Savitski team and Typas group describes their work on E. coli and how it brings a greater understanding of the way genes function and interact.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Changes in senior roles at EMBL
Three changes in senior staff positions have been confirmed at EMBL today. Jessica Vamathevan becomes Head of Strategy, Jan Korbel becomes Head of Data Science for EMBL Heidelberg, and Nassos Typas becomes Senior Scientist.
EMBL ANNOUNCEMENTSLAB MATTERS2020
embl-announcementslab-matters
Re-trafficking proteins to fight Salmonella infections
Scientists including members of EMBL’s Typas group have investigated how immune cells called macrophages respond to infection by the intracellular pathogen Salmonella enterica. They discovered that Salmonella causes newly produced cathepsins to accumulate in the nuclei of infected cells to…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
No results found